Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial of a monoclonal antibody therapy for stage IV melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Unspecified monoclonal antibody therapy (Phase 1)

Snippet

Sponsor: Mayo Clinic | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED